Pharma

Your Article Summary

See Latest Articles

Takeda, Amgen to suspend trials of cancer drug
Corporate News Releases - The Healthcare Sales & Marketing Network, 11/20/08

Japan's Takeda Pharmaceutical Co and U.S. biotech firm Amgen Inc said they would suspend enrolment in the last-stage trials of a key cancer drug candidate following negative study results.

Today in Regulatory Issues...keeping you current

Receive free subspecialty "5-minute updates" via email

Takeda Receives FDA Complete Response Letter for Alogliptin, An Investigational Treatment for Type 2 Diabetes
Takeda Pharmaceuticals North America, 07/02/09

Insulin detemir alert issued by FDA
American Pharmacists Association, 06/15/09

Court Grants Teva Summary Judgment Of Non-Infringement On Eloxatin
Teva Pharmaceutical Industries, 06/19/09

See All of Regulatory Issues